What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Understanding which assets have the highest returns can guide your investment strategy. Explore various options to enhance your portfolio.
25,689 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
A major fund trimmed its LKQ position by 777,000 shares, raising questions about what this means for the stock and th...
Retail investors are retreating from crypto while institutions step up exposure, reshaping liquidity and risk. The sh...
A surge in triple-leveraged ETFs has driven notional exposure to about $500 billion, intensifying daily volatility an...
Silicon Valley legend Vinod Khosla says he will remain in California despite a sweeping wealth tax proposal, urging l...
A sizable move in the First Trust QTEC fund has traders buzzing. Is the sale a warning sign for overheated AI stocks ...
A single stock rally can expose ETF flaws. Learn how this chip ready micron moment reshapes EMG chip ETFs and what to...
Crypto venture funds are widening bets beyond coins, aiming at fintech, AI, and infrastructure. The shift is designed...
Polychain Capital has secured a $200 million first close for its fourth crypto fund, with plans to reach roughly $400...
A Medicare cost shock is hitting many retirees in 2026. This guide breaks down what happened, how it could affect you...
Three active AI-focused ETFs are pulling ahead as corporate AI investments surge. This report explains why after mont...
Loopring has halted trading on its decentralized exchange, citing outdated zkRollup tech and a strategic pivot toward...